Optimizing Antibiotic Treatment Duration for ESBL-Producing Enterobacteriaceae Bacteremia in ICU: A Multicentric Retrospective Cohort Study
In our cohort, one quarter of patients with ESBL-E bacteremia acquired in the ICU surviving beyond 7 days were treated with a SAT. SAT did not appear to affect survival. Patients who could benefit from a SAT need to be better identified.
Authors
- Frédéric Wallet (ORCID: https://orcid.org/0000-0002-2368-5466)
- Marion Houard
- Perrine Bortolotti
- Saad Nseir (ORCID: https://orcid.org/0000-0002-7618-0357)
- Pierre Patoz (ORCID: https://orcid.org/0000-0003-1262-5430)
- Anne Vachée
- Lucie Benetazzo
- Maxime Degrendel
- Camille Le Berre
- Hugues Georges
- Pierre-Yves Delannoy
- Agnès Meybeck
Institutions
- Centre Hospitalier Universitaire de Lille (FR)
- Centre Hospitalier de Roubaix (FR)
- Centre Hospitalier de Tourcoing (FR)
- Centre Oscar Lambret (FR)
Publication Details
- Journal
- Antibiotics
- Published
- 2025-04-01
- DOI
- https://doi.org/10.3390/antibiotics14040358
- Citations
- 1
- Primary Topic
- Antibiotic Resistance in Bacteria
- Type
- article
- Field-Weighted Citation Impact
- 0.59